Document is current
Any future updates will be listed below
-
Authors
Buergy, Daniel
Siefert, Victor
Neumaier, Christian
Ganslandt, Thomas
Sperk, Elena
Blessing, Manuel
Hesser, Jürgen
Welzel, Grit
Wenz, Frederik
Giordano, Frank Anton https://orcid.org/0000-0001-5243-4781
- License Information
-
More Information
Article History
Received: 1 July 2019
Accepted: 30 October 2019
First Online: 18 November 2019
Conflict of interest
: D. Buergy reports personal fees from Siemens AG, personal fees from NB Capital Research GmbH, personal fees from NB Capital ApS, and personal fees from b.e. Imaging GmbH outside the submitted work. E. Sperk reports grants, travel compensation, and personal fees from Carl Zeiss Meditec AG. G. Welzel reports non-financial support from Carl Zeiss Meditec AG outside the submitted work, and honoraria from Roche Pharma AG outside the submitted work. F. Wenz reports grants and personal fees from Elekta AB, Sweden, personal fees from Roche Pharma AG, grants, personal fees, and other from Carl Zeiss Meditec AG, personal fees from Celgene GmbH, personal fees from Eli Lilly and Company, and personal fees from Ipsen Pharma GmbH outside the submitted work. F.A. Giordano reports grants and personal fees from NOXXON Pharma AG, grants and personal fees from Carl Zeiss Meditec AG, personal fees from Bristol-Myers Squibb, personal fees from Roche Pharma AG, personal fees from MSD Sharp and Dohme GmbH, personal fees from AstraZeneca GmbH, grants and travel compensation from Elekta AB, and shares from Implacit GmbH. V. Siefert, C. Neumaier, T. Ganslandt, M. Blessing, J. Hesser, and G. Welzel, declare that they have no competing interests.
